missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human Adenosine Deaminase/ADA Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity

Marke:  R&D Systems™ 7048-AD-010

Artikelnummer. 18126620

  • 525.00 CHF / 10 Mikrogramm
Verfügbar ab: 15-01-2025
Sie sich ein, um den Lagerbestand zu sehen
Entdecken Sie weitere Sonderangebote
Add to basket
This item is not returnable. View return policy

Description

Description

The Recombinant Human Adenosine Deaminase/ADA Protein is derived from Sf 21 (baculovirus). The Recombinant Human Adenosine Deaminase/ADA Protein has been validated for the following applications: Enzyme Activity.
Specifications

Specifications

Supplied as a 0.2μm filtered solution in MOPS, NaCl and Tween™ 80.
42 kDa
10 μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
Recombinant
100
Adenosine Deaminase/ADA
Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Adenosine Deaminase/ADA protein Met1-Leu363,with a C-terminal 6-His tag
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain at 5 μg per lane.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.